Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Andrew B. Song & Hanny Al-Samkari. (2023) Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert Review of Hematology 16:5, pages 365-375.
Read now
Read now
Hanny Al‐Samkari & Gerald A. Soff. (2021) Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia. Expert Review of Hematology 14:5, pages 437-448.
Read now
Read now
Stephen A. Strickland, Xin Victoria Wang, Jan Cerny, Jacob M. Rowe, Witold Rybka, Martin S. Tallman, Mark Litzow & Hillard M. Lazarus. (2020) A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia. Leukemia & Lymphoma 61:9, pages 2191-2199.
Read now
Read now
Sif Gudbrandsdottir, Henrik Frederiksen & Hans Hasselbalch. (2012) Thrombopoietin-receptor agonists in haematological disorders: The Danish experience. Platelets 23:6, pages 423-429.
Read now
Read now
Articles from other publishers (43)
Wen Chen, Yubingxue Liu, Luchun Li & Xianghua Zeng. (2023) Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis. BMC Pharmacology and Toxicology 24:1.
Crossref
Crossref
Gerald Soff, Avi Leader, Hanny Al-Samkari, Anna Falanga, Anthony Maraveyas, Kristen Sanfilippo, Tzu-Fei Wang & Jeffrey Zwicker. (2023) Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy. Journal of Thrombosis and Haemostasis.
Crossref
Crossref
Hanny Al-Samkari. (2023) Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists. Blood Reviews, pages 101139.
Crossref
Crossref
Ai Gao, Linlin Zhang & Diansheng Zhong. (2023) Chemotherapy-induced thrombocytopenia: literature review. Discover Oncology 14:1.
Crossref
Crossref
Hanny Al-Samkari. (2022) Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem. Hematology 2022:1, pages 286-295.
Crossref
Crossref
Abdulkadir Erçalışkan, Fatma Zehra Avcı & Ahmet Emre Eşkazan. (2022) Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia. Turkish Journal of Hematology 39:4, pages 275-276.
Crossref
Crossref
Yayun Cui, Yifu He, Changlu Hu, Congyin Tu, Jin Huang, Xiaofeng Zhu, Chunbao Zang, Kaiyang Ding, Bihong Zhan, Yufei Zhao & Liting Qian. (2022) Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial. Frontiers in Pharmacology 13.
Crossref
Crossref
Gerald A. Soff, Isabelle Ray-Coquard, Luis J. Marfil Rivera, Jon Fryzek, Megan Mullins, Lauren C. Bylsma & Joseph K. Park. (2022) Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia. PLOS ONE 17:6, pages e0257673.
Crossref
Crossref
David J. Kuter. (2022) Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies. Haematologica 107:6, pages 1243-1263.
Crossref
Crossref
Irene Marini, Gunalp Uzun, Kinan Jamal & Tamam Bakchoul. (2022) Treatment of drug-induced immune thrombocytopenias. Haematologica 107:6, pages 1264-1277.
Crossref
Crossref
Hanny Al-Samkari, Jaroslaw Kolb-Sielecki, Sufiia Z Safina, Xiaoqiang Xue & Brian D Jamieson. (2022) Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Haematology 9:3, pages e179-e189.
Crossref
Crossref
Hyerim Ha & Joo Han Lim. (2022) Managing Side Effects of Cytotoxic Chemotherapy in Patients With High Grade Gliomas. Brain Tumor Research and Treatment 10:3, pages 158.
Crossref
Crossref
Qiuhua Zhu, Shimei Yang, Wenbin Zeng, Mingjie Li, Zebing Guan, Lanlan Zhou, Hong Wang, Yanan Liu, Yanmin Gao, Shiqiu Qiu, Chaolun Chen, Huan Li, Shanshan Zheng, Yuemei Yuan, Hanling Zhang & Xueyi Pan. (2021) A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia. Frontiers in Oncology 11.
Crossref
Crossref
Francesco Paciullo, Loredana Bury & Paolo Gresele. (2020) Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer. International Journal of Hematology 112:5, pages 725-727.
Crossref
Crossref
Sara Singer & Basem M. William. (2020) Use of thrombopoietin receptor agonists after hematopoietic progenitor cell transplantation. ADVANCES IN CELL AND GENE THERAPY 3:4.
Crossref
Crossref
Axel Matzdorff. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
4
.
Jodi V. Mones & Gerald Soff. 2019. Thrombosis and Hemostasis in Cancer. Thrombosis and Hemostasis in Cancer
139
150
.
Taisuke KanajiMy-Nuong VoSachiko KanajiAlessandro ZarpellonRyan ShapiroYosuke MorodomiAkinori YuzurihaKoji EtoRajesh BelaniMinh-Ha DoXiang-Lei YangZaverio M. Ruggeri & Paul Schimmel. (2018) Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia. Proceedings of the National Academy of Sciences 115:35.
Crossref
Crossref
Yi-Hong Wu, Hsing-Yu Chen, Chyong-Huey Lai, Chein-Shuo Yeh, Jong-Hwei S. Pang, Jian-Tai Qiu, Hung-Hsueh Chou, Lan-Yan Yang & Yu-Bin Pan. (2018) Use of Chinese Herbal Medicine Improves Chemotherapy-Induced Thrombocytopenia among Gynecological Cancer Patients: An Observational Study. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-8.
Crossref
Crossref
Jenny Despotovic & Amanda Grimes. 2018. Antibody Therapy. Antibody Therapy
261
276
.
Eric S. Winer, Howard Safran, Boguslawa Karaszewska, Sebastian Bauer, Dilawar Khan, Steffen Doerfel, Paul Burgess, Stacey Kalambakas, Yasser Mostafa Kamel & Frederic Forget. (2017) Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study. International Journal of Hematology 106:6, pages 765-776.
Crossref
Crossref
Xia Zhang, Yunhai Chuai, Wei Nie, Aiming Wang & Guanghai Dai. (2017) Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours. Cochrane Database of Systematic Reviews 2017:11.
Crossref
Crossref
Harinder Gill, Raymond S. M. Wong & Yok-Lam Kwong. (2017) From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Therapeutic Advances in Hematology 8:5, pages 159-174.
Crossref
Crossref
Michael D. Tarantino & Sarah Chalmers. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders
1417
1429
.
Caroline I. Piatek & Howard A. Liebman. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders
841
850
.
Michael Desborough, Lise J Estcourt, Carolyn Doree, Marialena Trivella, Sally Hopewell, Simon J Stanworth & Michael F Murphy. (2016) Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Takashi Tanaka, Yoshihiro Inamoto, Takuya Yamashita, Shigeo Fuji, Keiji Okinaka, Saiko Kurosawa, Sung-Won Kim, Ryuji Tanosaki & Takahiro Fukuda. (2016) Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 22:5, pages 919-924.
Crossref
Crossref
Xia Zhang, Yunhai Chuai, Wei Nie, Aiming Wang & Guanghai Dai. (2016) Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ferrán Catalá-López, Inmaculada Corrales, César de la Fuente-Honrubia, Diana González-Bermejo, Gloria Martín-Serrano, Dolores Montero & Diego Macías Saint-Gerons. (2015) Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials. Medicina Clínica 145:12, pages 511-519.
Crossref
Crossref
Ferrán Catalá-López, Inmaculada Corrales, César de la Fuente-Honrubia, Diana González-Bermejo, Gloria Martín-Serrano, Dolores Montero & Diego Macías Saint-Gerons. (2015) Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials. Medicina Clínica (English Edition) 145:12, pages 511-519.
Crossref
Crossref
Patricia L. McElroy, Ping Wei, Keri Buck, Angus M. Sinclair, Michael Eschenberg, Barbra Sasu & Graham Molineux. (2015) Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopenia. Experimental Hematology 43:6, pages 479-487.
Crossref
Crossref
Eric S. Winer, Howard Safran, Boguslawa Karaszewska, Donald A. Richards, Lee Hartner, Frederic Forget, Rodryg Ramlau, Kirushna Kumar, Bhabita Mayer, Brendan M. Johnson, Conrad A. Messam & Yasser Mostafa Kamel. (2014) Eltrombopag with gemcitabine‐based chemotherapy in patients with advanced solid tumors: a randomized phase I study. Cancer Medicine 4:1, pages 16-26.
Crossref
Crossref
Caizheng Li & Li Zheng. (2014) The pharmacology and clinical application of thrombopoietin receptor agonists. International Journal of Hematology 100:6, pages 529-539.
Crossref
Crossref
Howard A. Liebman. (2014) Thrombocytopenia in cancer patients. Thrombosis Research 133, pages S63-S69.
Crossref
Crossref
Sant P Chawla, Arthur Staddon, Andrew Hendifar, Conrad A Messam, Rita Patwardhan & Yasser Yasser Mostafa Kamel. (2013) Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide. BMC Cancer 13:1.
Crossref
Crossref
Jane L. Liesveld, Gordon L. PhillipsIIII, Michael Becker, Louis S. Constine, Jonathan Friedberg, Jeffrey R. Andolina, Laurie A. Milner, Jessica DeBolt, Therese Smudzin, Ollivier Hyrien, Connie L. Erickson-Miller, Brendan M. Johnson, Katie-Louise Dawson & Yuhchyau Chen. (2013) A Phase 1 Trial of Eltrombopag in Patients Undergoing Stem Cell Transplantation after Total Body Irradiation. Biology of Blood and Marrow Transplantation 19:12, pages 1745-1752.
Crossref
Crossref
Siobhan Hayes, Paul N. MuddJr.Jr., Daniele Ouellet, Brendan M. Johnson, Daphne Williams & Ekaterina Gibiansky. (2013) Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia. Cancer Chemotherapy and Pharmacology 71:6, pages 1507-1520.
Crossref
Crossref
Bernhard Wörmann. (2013) Clinical Indications for Thrombopoietin and Thrombopoietin-Receptor Agonists. Transfusion Medicine and Hemotherapy 40:5, pages 319-325.
Crossref
Crossref
Ferrán Catalá-López, Inmaculada Corrales, Gloria Martín-Serrano, Aurelio Tobías & Gonzalo Calvo. (2012) Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials. Medicina Clínica 139:10, pages 421-429.
Crossref
Crossref
Michael RothBritta WillGuillermo SimkinSwathi NarayanagariLaura BarreyroBoris BartholdyRoni TamariConstantine S. MitsiadesAmit Verma & Ulrich Steidl. (2012) Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood 120:2, pages 386-394.
Crossref
Crossref
Mary B. Wire, Heidi B. McLean, Carolyn Pendry, Dickens Theodore, Jung W. Park & Bin Peng. (2012) Assessment of the Pharmacokinetic Interaction between Eltrombopag and Lopinavir-Ritonavir in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy 56:6, pages 2846-2851.
Crossref
Crossref
J. Paul Duic, Jai Grewal, Kerry McConie, Harry Staszewski, Jonathan Haas & Santosh Kesari. (2011) Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. Journal of Neuro-Oncology 106:2, pages 427-429.
Crossref
Crossref
Yang Zhang & Jill M. Kolesar. (2011) Eltrombopag: An Oral Thrombopoietin Receptor Agonist for the Treatment of Idiopathic Thrombocytopenic Purpura. Clinical Therapeutics 33:11, pages 1560-1576.
Crossref
Crossref